Anthony P Adamis is of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 4,000 shares of EYPT, which is worth approximately $47,040. The most recent transaction as insider was on Jun 23, 2024, when has been sold 2,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K
0% 3M change
100.0% 12M change
Total Value Held $47,040

ANTHONY P ADAMIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2024
BUY
Exercise of conversion of derivative security
-
2,000 Added 33.33%
4,000 Common Stock
Jun 23 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 50.0%
2,000 Common Stock
APA

Anthony P Adamis

Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT